No_foto

Dr. Juan Francisco Santibáñez Domínguez

El Dr. Santibáñez recibió su grado de bioquímico de la Universidad de Santiago en el año 1990. En el año 1999 recibió su grado de Doctor en Ciencias Biológicas de la Universidad Autónoma de Madrid.


Publicaciones

    1. Mojsilovic SS, Tosic M, Mojsilovic S, Zivanovic M, Bjelica S, Srdic-Rajic T and Santibanez JF. Paclitaxel Inhibits Transforming Growth Factor-b-increased urokinase-type plasminogen activator expression trough p38 MAPK and RAW 264.7 Macrophage Migration. JBUON, 2020, 1257-65
    2. Echeverria C, Eltit F, Santibanez JF, Gatica S, Cabello-Verrugio C, Simon F. Endothelial Dysfunction in Pregnancy Metabolic Disorders. Biochim Biophys Acta Mol Basis Dis. 2020, 165414
    3. Bjelica S, Diklić M, Đikić D, Kovačić M, Subotički T, Mitrović-Ajtić O, Radojković M, Čokić VP, Santibanez JF. Hydroxyurea-induced senescent peripheral blood mesenchymal stromal cells inhibit bystander cell proliferation of JAK2V617F-positive human erythroleukemia cells. FEBS J., 2019, 3647-3663.
    4. Subotički T, Mitrović Ajtić O, Beleslin-Čokić BB, Bjelica S, Djikić D, Diklić M, Leković D, Gotić M, Santibanez JF, Noguchi CT, Čokić VP. IL-6 Stimulation of DNA Replication Is JAK1/2 Mediated in Cross-Talk With Hyperactivated ERK1/2 Signaling. Cell Biol Int. 2019, 192-206
    5. Gatica S, Eltit F, Santibanez JF, Varela D, Cabello-Verrugio C, Simon F. Expression Suppression and Activity Inhibition of TRPM7 Regulate Cytokine Production and Multiple Organ Dysfunction Syndrome During Endotoxemia: A New Target for Sepsis. Curr Mol Med., 2019, 547-559
    6. Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. How to Measure the Immunosuppressive Activity of MDSC: Assays, Problems and Potential Solutions. Cancer Immunol Immunother, 2019, 631-644
    7. Umansky V, Adema GJ, Baran J, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KCM, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG. Interactions Among Myeloid Regulatory Cells in Cancer, Cancer Immunol Immunother, 2019, 645-660
    8. Mojsilovic SS, Mojsilovic S, Bjelica S, Santibanez JF. Estramustine Phosphate Inhibits TGF- β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production, Anal Cell Pathol (Amst), 2018, 3134102
    9. Millan C, Vivanco JF, Benjumeda-Wijnhoven IM, Bjelica S, Santibanez JF. Mesenchymal Stem Cells and Calcium Phosphate Bioceramics: Implications in Periodontal Bone Regeneration, Adv Exp Med Biol, 2018, 91-112
    10. Santibanez JF, Bjelica S. Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation, Recent Pat Anticancer Drug Discov, 2018, 133-144
    11. Santibanez JF, Krstic J. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer, Curr Protein Pept Sci., 2018, 1155-1163
    12. Santibanez JF, Obradović H, Kukolj T, Krstić J., Transforming Growth factor-β, Matrix Metalloproteinases, and Urokinase-Type Plasminogen Activator Interaction in the Cancer Epithelial to Mesenchymal Transition, Dev Dyn., 2018, 382-395.
    13. Srdic-Rajic T, Santibañez JF, Kanjer K, Tisma-Miletic N, Cavic M, Galun D, Jevric M, Kardum N, Konic-Ristic A, Zoranovic T. Iscador Qu Inhibits Doxorubicin-Induced Senescence of MCF7 Cells., Sci. Rep. 2017, 3763.
    14. Santibanez JF. Urokinase Type Plasminogen Activator and the Molecular Mechanisms of Its Regulation in Cancer, Protein Pept Lett., 2017, 936-946
    15. Cabello-Verrugio C, Simon F, Trollet C, Santibañez JF. Oxidative Stress in Disease and Aging: Mechanisms and Therapies 2016. Oxid Med Cell Longev., 2017, 4310469.
    16. Trivanović D, Krstić J, Djordjević IO, Mojsilović S, Santibanez JF, Bugarski D, Jauković A. The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated With Inflammation., Mediators Inflamm., 2016, 7314016
Translate »